Immunosuppressive agents (such as anti-tumor necrosis factor-α, anti-TNF-α [14]) can suppress the proliferation of inflammatory cells [15], and they are generally used in the treatment of patients with Crohn’s disease (CD) [16]. This evidence concerns the gene TNF and Crohn disease.